Phase 1B Study of PD-0332991 in Combination With T-DM1 in the Treatment of Patients With Advanced HER2 (Human Epidermal Growth Factor Receptor 2)-Positive Breast Cancer
Phase of Trial: Phase I
Latest Information Update: 16 Jun 2016
At a glance
- Drugs Palbociclib (Primary) ; Trastuzumab emtansine
- Indications Breast cancer; Male breast cancer
- Focus Adverse reactions
- 07 Jun 2017 Biomarkers information updated
- 07 Jun 2016 Planned End Date changed from 1 Dec 2016 to 1 Dec 2017.
- 07 Jun 2016 Planned primary completion date changed from 1 Dec 2016 to 1 Dec 2017.